Top

International Journal of Hematology

Published in:

01-10-2004 | Letter to the Editor

Genetic Polymorphism of the CYP2C9 Subfamily of 3 Different Races in Warfarin Maintenance Dose

Authors: Gin Gin Gan, Alan Teh, Vijaya Sangkar, Maude Elvira Phipps, Chee Seng Ku

Published in: International Journal of Hematology | Issue 3/2004

Title: Genetic Polymorphism of the CYP2C9 Subfamily of 3 Different Races in Warfarin Maintenance Dose
Authors: Gin Gin Gan
Alan Teh
Vijaya Sangkar
Maude Elvira Phipps
Chee Seng Ku
Publication date: 01-10-2004
Publisher: Springer Japan
Published in: International Journal of Hematology / Issue 3/2004
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI: https://doi.org/10.1532/IJH97.A20401

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The STEP trials

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 3/2004

Gene Expression Profiling of Human Erythroid Progenitors by Micro-Serial analysis of Gene Expression

Successful Treatment with Cyclosporine and High-Dose Gamma Immunoglobulin for Persistent Parvovirus b19 Infection in a Patient with Refractory Autoimmune Hemolytic Anemia

Survivin and Leukemia

Successful Unrelated Cord Blood Transplantation Using a Reduced-Intensity Conditioning Regimen in a 6-Month-Old Infant with Congenital Neutropenia Complicated by Severe Pneumonia

Aleukemic Leukemia Cutis in a Patient with Philadelphia Chromosome-Positive Biphenotypic Leukemia

Cytokine-Mediated Cell Survival

Keynote webinar | Spotlight on antibody–drug conjugates in cancer